Francais | Home | Contact us
Rank Ligand
  • RANK L in
    Healthy Bone
  • RANK L in metastatic
    Bone Disease
  • Bone Metastases
    and SREs
  • Prostate
    Cancer
  • Breast
    Cancer
  • Get to know the KEY PLAYERS in the vicious
    cycle of metastatic bone destruction.
  • Vicious Cycle
  • Click to Play

Site map

The vicious cycle

  • RANK L in healthy bone
    • Balancing resorption and formation
    • RL is essential to osteoclast function
    • RANK Ligand and OPG balance bone loss and formation
  • RANK L in metastatic bone disease
    • Osteoblastic vs osteolytic bone mets
    • RL drives the vicious cycle
  • Bone metastases and SREs
    • Incidence of mets
    • Incidence of SREs
    • Subsequent SREs
    • Bone pain and mets
  • Prostate cancer
    • Bone metastases and skeletal-related events (SREs) in prostate cancer.
    • The skeleton is the most common site affected by metastatic prostate cancer5
  • Breast cancer
    • SREs in breast cancer
    • Subsequent SREs
    • SREs increase mortality in breast
  • Contact Us
  • Privacy & Terms
    • Terms
    • Privacy
  • Site Map
AMGEN Oncology

This site is intended for use by Canadian Healthcare Professionals only

© 2010 Amgen. All rights reserved. Contact us | Site map | Privacy & terms

Member R&D, PAAB